GLP-1 Agonists

Cagrilintide + Semaglutide Blend (CagriSema)

Catalog #: CS

CagriSema research blend: Cagrilintide (amylin) + Semaglutide (GLP-1) — dual-pathway metabolic combination targeting distinct neuronal satiety populations for next-generation obesity and metabolic research.

Catalog Number CS
Component A Cagrilintide (amylin analog)
Component B Semaglutide (GLP-1R agonist)
Targets AMY1/2/3 (brainstem) + GLP-1R (hypothalamus)

Available SKUs

Model Specification MOQ
CS5 Cagrilintide 2.5mg + Semaglutide 2.5mg / 10ml 1 vial
CS10 Cagrilintide 5mg + Semaglutide 5mg / 10ml 1 vial
Ships within 5-7 business days
Certificate of Analysis included
Quality guaranteed

Product Overview

CagriSema research blend: Cagrilintide (amylin) + Semaglutide (GLP-1) — dual-pathway metabolic combination targeting distinct neuronal satiety populations for next-generation obesity and metabolic research.

Research Applications

  • Amylin + GLP-1 dual-pathway metabolic research blend
  • Targets distinct neuronal populations for synergistic satiety
  • Brainstem (amylin) + hypothalamus (GLP-1) convergent signaling
  • Next-generation multi-agonist research paradigm
  • ≥99% purity per component

Key Features

  • For laboratory research use only

Technical Support

Our team of product experts is available to assist with your research needs.

Contact Support

OEM Services

Need modifications or larger quantities? Request a custom synthesis quote.

Request Custom
Catalog Number CS
Component A Cagrilintide (amylin analog)
Component B Semaglutide (GLP-1R agonist)
Targets AMY1/2/3 (brainstem) + GLP-1R (hypothalamus)
Form Co-lyophilized powder
Purity ≥99% per component
Storage -20°C, desiccated

Related Products

Need OEM or a Custom Configuration?

We support practical, production-ready customization for peptides, sequences, and modifications. Share your synthesizer type, dimensions, modifications preference, and packaging needs—our team will confirm feasibility and lead time.

Request Custom Synthesis Contact Us